The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
The company has reported total income of Rs.3031 crores during the calendar year ended December 31, 2021.
Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.
The transaction as well as the open offer is expected to be completed by June this year.
Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.
The company registered consolidated total revenue of Rs 590.70 crore for Q3FY22.
Key takeaways of recent quarter & conference call highlights
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
Granules India has reported consolidated financial results for the period ended December 31, 2021
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
